• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 07C18-41
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/27/2023
Event Type  malfunction  
Event Description
The customer observed a falsely elevated architect anti-hbs result for one patient.The following data was provided: (b)(6) 2023 sid (b)(6) anti-hbs initial result = 20.62 miu/ml, elisa = nonreactive no impact to patient management was reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7c18 has a similar product distributed in the us, list number 1l82.
 
Manufacturer Narrative
The complaint investigation for the architect anti-hbs assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing.Additionally, return sample analysis was completed.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A search for similar complaints did not identify an increase in complaint activity for lot 51439fn00.A review of tracking and trending did not identify any related trends for the product for the issue.Device history record review on lot 51439fn00 did not identify any nonconformance's or deviations associated with lot number 51439fn00 and complaint issue.Labeling was reviewed and found to adequately address the issue under review.In-house specificity testing was completed with lot number 51439fn00.Testing met all acceptance criteria indicating the product is performing as expected and there is no issue with the lot.Return sample analysis: the returned specimen (sample id 824034) was tested with the architect anti-hbs reagent, lot 51439fn00.The reactive result obtained by the customer was replicated.Additional reference testing and testing with heterophilic blocking tubes (hbt) could not be performed as insufficient sample volume remained.However, test results (architect hiv ag/ab) for additional samples from the same patient tested with hbt indicates that the false reactive results were caused by interference due to heterophilic antibodies.Based on the investigation, no systemic issue or deficiency of the architect anti-hbs reagent for lot number 51439fn00 was identified.
 
Event Description
The customer observed a falsely elevated architect anti-hbs result for one patient.The following data was provided: (b)(6)2023 sid (b)(6)anti-hbs initial result = 20.62 miu/ml, elisa = nonreactive no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18330224
MDR Text Key330959394
Report Number3008344661-2023-00198
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P050051
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07C18-41
Device Lot Number51439FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
-
-